Voice biomarker platform Sonde Well being raises $19.25M to unfold entry to psychological well being monitoring and past
Voice analysis platform Sonde Health raises $19.25M (MobiWell beingInformation):
AI-enabled voice technology plattype Sonde Well being introduced it raised $19.25 million in a Collection B funding spherical led by Halfners Make investmentsment, carrying its whole increase to $35.25 million … Sonde Well being makes use of patented voice technology to detect various well being conditions from biomarkers in a person’s voice, including analyzing respiratory matchness and detecting depression and nervousness.
The funding will assist construct out the company’s technology to detect additional well being conditions, develop its curlease respiratory and malestal health-monitoring technologies, and drive global commercial development.
“Digital biomarkers are becoming a principalkeep in well beingcare. As we speak’s well beingcare companies are actualizing how vocal biomarkers can have interaction people earlier of their well being. The information and insights present in voice can power well being monitoring and affected person stratification so points can turn out to be apparent nicely earlier than a pricely medical occasion happens,” David Liu, CEO of Sonde Well being, stated in a statement. “With voice and any listening system, accessible and effective well being monitoring may be made availin a position to the mainity of the world.”
Sonde Health Raises $19.25 Million Series B to Build the Next Generation of Voice-Based Health Monitoring (press launch):
Sonde Well being, a well being technology company committed to carrying accessible well being monitoring to eachone, has raised a $19.25 million Collection B make investmentsment spherical … The company has raised $35.25 million in whole and can use the funding to drive its global commercial development, deepen its respiratory and malestal well being monitoring technologies, and construct capabilities for additional well being situations.
Sonde licenses its plattype to customers globally in two methods:
Well being Checks
- Respiratory Matchness: Sonde’s plattype can detect and monitor respiratory well being conditions, like asthma, from 6 seconds of voice. Sufferers are engaging with Sonde’s respiratory matchness well being checks 2+ occasions per week.
- Malestal Matchness: Sonde’s plattype can detect and monitor evidence of depression and anxiety from 30 seconds of voice. Sufferers are engaging with Sonde’s malestal matchness well being checks 3+ occasions per week.
Vocal Biomarker Growth
- MCI, COPD, General Well being: Sonde is developing novel vocal biomarkers utilizing its professionalprietary “research-build-validation” techniqueology with clinical companions.
… GN Group will integrate Sonde’s Malestal Matchness vocal biomarker into its hearing products. The company is already working with Sonde to develop an MCI vocal biomarker. Qualcomm, which has already integrated Sonde’s vocal biomarkers into its cellular system chipsets, has lengthened the relationship to incorporate its put onready chipsets. Koye Pharmaceuticals, which had already engaged Sonde to develop a COPD vocal biomarker, has developed the halfnership to develop a novel malestal well being vocal biomarker for deployment in India.